I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN

Net Margin

-1 325.5%
Current
Declining
by 979.7%
vs 3-y average of -345.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1 325.5%
=
Net Income
zł-6.1m
/
Revenue
zł462k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1 325.5%
=
Net Income
zł-6.1m
/
Revenue
zł462k

Peer Comparison

Country Company Market Cap Net
Margin
PL
Inno-Gene SA
WSE:IGN
17.7m PLN
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
240.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
171B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
281.9B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.8T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.8B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in Poland
Percentile
5th
Based on 886 companies
5th percentile
-1 325.5%
Low
-9 940 700% — -3.7%
Typical Range
-3.7% — 9.1%
High
9.1% — 196 605.3%
Distribution Statistics
Poland
Min -9 940 700%
30th Percentile -3.7%
Median 2.9%
70th Percentile 9.1%
Max 196 605.3%

Inno-Gene SA
Glance View

Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.

IGN Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-1 325.5%
=
Net Income
zł-6.1m
/
Revenue
zł462k
What is Inno-Gene SA's current Net Margin?

The current Net Margin for Inno-Gene SA is -1 325.5%, which is below its 3-year median of -345.8%.

How has Net Margin changed over time?

Over the last 3 years, Inno-Gene SA’s Net Margin has decreased from 40% to -1 325.5%. During this period, it reached a low of -1 325.5% on Jul 30, 2024 and a high of 40% on May 30, 2021.

Back to Top